March 7th 2024
Differences in bone density and FRAX fracture risk scores among Black and Asian women yield greater discordance in fracture risk estimation compared with White women.
Study Evaluates Bone Health in Children With Acute Lymphoblastic Leukemia
July 10th 2018Acute lymphoblastic leukemia is the most common type of childhood cancer, and fractures from osteoporosis are an important cause of morbidity in patients with ALL. A recent study aimed to document the annual incidence and predictors of fractures in order to determine whether they occur years after chemotherapy.
Read More
Explosive Jumping Can Help Prevent Falls in Women With Osteoporosis Risk
July 7th 2018Can older women with low bone mass decrease their risk of falls with a fitness trend called explosive jumping? One study says it’s possible, and that it may be worthwhile to incorporate muscle power training into traditional fall-prevention programs.
Read More
USPSTF Updates Screening Recommendations for Osteoporosis
June 26th 2018The United States Preventive Services Task Force (USPSTF) updated its 2011 recommendation about osteoporosis screening, recommending that women over the age of 65 years continue to get screened and issuing new information about how clinicians should use screening tools to evaluate women younger than 65 years at high risk for developing the bone disease.
Read More
Pfenex Reports Good Results of Biosimilar for Osteoporosis
June 12th 2018Biotechnology firm Pfenex recently reported results from its phase 3 PF708-301 study, which showed comparable overall profiles between its biosimiliar drug candidate PF708 and Eli Lilly’s teriparatide (Forteo) for osteoporosis.
Read More
Denosumab Shows Good Results in Glucocorticoid-Induced Osteoporosis
June 11th 2018A study comparing denosumab (Prolia) with risedronate (Actone) found that denosumab could be a useful treatment option for patients newly initiating or continuing glucocorticoids who are at risk of fractures. It is the first study to show that denosumab can increase bone mineral density at both the spine and the hip in patients with glucocorticoid-induced osteoporosis.
Read More
Discovery About Rare Bone Disease May Also Hold Clues About Bone Health
April 12th 2018National Institutes of Health researchers have uncovered a genetic basis of a rare bone disease known as melorheostosis and said the discovery could offer potential treatment targets, provide clues about bone development, and lead to insights about fracture healing and osteoporosis.
Read More
Trends in Bisphosphonate Initiation Within an Integrated Healthcare Delivery System
The authors observed a marked shift toward treatment of higher-risk subsets of younger postmenopausal women (with prior fracture and/or with osteoporosis), and away from women at lower risk.
Read More